FDA Announces Dates for Public Meeting on Non-Steroidal Anti-Inflammatory Drugs

The Food and Drug Administration (FDA) has announced a joint public meeting of the agency's Arthritis Advisory Committee
and the Drug Safety and Risk Management Advisory Committee to be held February 16, 17 and 18, 2005.


The committees will discuss the overall benefit-to-risk considerations (including cardiovascular and gastrointestinal
concerns) for COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) and related medicines.


Members of the public are encouraged to participate in this meeting. Interested persons may present data, information or
views, orally or in writing, on issues pending before the committees. Oral presentations from the public will be scheduled
between 1:00 p.m. and 3:00 p.m. on February 17. Time allotted for each presentation may be limited. Those desiring to make
formal oral presentations should register to speak at the meeting before February 4, 2005. No registration is required for
those only planning on attending the meeting.


The three-day meeting will be held at the Hilton Washington DC North, 620 Perry Parkway, Gaithersburg, Md. The proceedings
will start at 8:00 a.m. each day. Agendas and other background materials will be posted online no later than one business day
before the meeting.


For more information regarding this meeting, including contact information for members of the public interested in making
presentations or submitting written comments please CLICK HERE.


Media Inquiries: 301-827-6242

Consumer Inquiries: 888-INFO-FDA

This is an FDA Press Release